Shareholder Alert: Robbins LLP Reminds Investors that SunPower Corporation (SPWR) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of persons or entities that purchased or otherwise acquired SunPower Corporation (NASDAQ: SPWR) securities between August 3, 2021 and January 20, 2022, for violations of the Securities Exchange Act of 1934. SunPower is a solar energy company.

If you suffered a loss due to SunPower Corporation's misconduct, click here.

What is this Case About: SunPower Corporation (SPWR) Failed to Disclose Certain of its Connectors Suffered from Cracking Issues

According to the complaint, on January 20, 2022, SunPower announced it had "identified a cracking issue that developed over time in certain factory-installed connectors." The Company "expects approximately $27 million of supplier-quality related charges in the fourth quarter 2021 and approximately $4 million in the first quarter of 2022" to replace faulty connectors. On this news, shares of SunPower stock fell $3.22, or almost 17%, to close at $15.80 per share on January 21, 2022.

Next Steps: If you purchased shares of SunPower Corporation (SPWR) between August 3, 2021 and January 20, 2022, you have until April 18, 2022, to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against SunPower Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Industry:

Robbins LLP

NASDAQ:SPWR

Release Summary

SunPower Corporation (SPWR) Failed to Disclose Certain of its Connectors Suffered from Cracking Issues

Release Versions

$Cashtags

Hashtags

#shareholderrightslaw

#stockholderrightslaw

#stockmarket

#stocks

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Urges ZoomInfo Technologies Inc. Stockholders to Contact the Firm for Information About the Class Action Against GTM

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ZoomInfo Technologies Inc. (NASDAQ: GTM) securities between November 3, 2025 and May 11, 2026. ZoomInfo Technologies Inc., together with its subsidiaries, provides go-to-market intelligence and engagement platform for sales, marketing, operations, and recruiting professionals in the United States and internationally.For more information, submit...

Erasca, Inc. Class Action Reminder - Robbins LLP Encourages ERAS Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) securities between January 14, 2025 and April 26, 2026. Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call...

ADMA Biologics, Inc. Stock Drop: Robbins LLP Urges Investors to Contact the Firm for Information About the Class Action Against ADMA Biologics, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ: ADMA) securities between August 9, 2024 and March 25, 2026. ADMA Biologics, Inc. is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. For more information...

Back to Newsroom